FDA Inspection 980985 — Zhejiang Bangli Medical Products Co., Ltd
The FDA completed an inspection of Zhejiang Bangli Medical Products Co., Ltd on August 17, 2016 in Yongkang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 17, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yongkang (China)